Several novel mechanistic findings regarding to arsenic's pathogenesis has been reported and some of them suggest that the etiology of some arsenic induced diseases are due in part to heritable changes to the genome via epigenetic processes such as DNA methylation, histone maintenance, and mRNA expression. Recently, we reported that arsenic exposure during in utero and early life was associated with impairment in the lung function and abnormal receptor for advanced glycation endproducts (RAGE), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) sputum levels. Based on our results and the reported arsenic impacts on DNA methylation, we designed this study in our cohort of children exposed in utero and early childhood to arsenic with the aim to associate DNA methylation of MMP9, TIMP1 and RAGE genes with its protein sputum levels and with urinary and toenail arsenic levels. The results disclosed hypermethylation in MMP9 promotor region in the most exposed children; and an increase in the RAGE sputum levels among children with the mid methylation level; there were also positive associations between MMP9 DNA methylation with arsenic toenail concentrations; RAGE DNA methylation with iAs, and %DMA; and finally between TIMP1 DNA methylation with the first arsenic methylation. A negative correlation between MMP9 sputum levels with its DNA methylation was registered. In conclusion, arsenic levels were positive associated with the DNA methylation of extracellular matrix remodeling genes;, which in turn could modifies the biological process in which they are involved causing or predisposing to lung diseases.
Introduction
Arsenic contamination is a serious and widespread global public health problem with a significant known groundwater burden in countries such as Argentina, Bangladesh, Chile, China, Ghana, India, Mexico, Taiwan, the United States, and Vietnam. It is estimated that N 200 million people are at risk of toxic arsenic exposure (Hunt et al., 2014) .
Chronic arsenic exposure damages a broad range of organs systems in a time-and dose-dependent manner and the severity of its effects have been related with the different stages of the human development. Exposure to arsenic during pregnancy affects human developmental processes resulting in lower birth weight, increased infant mortality, and neurological and intellectual impairments in children (Naujokas et al., 2013) . As well, it has been reported that subjects suffering from arsenic toxicity are more susceptible to pulmonary diseases, conditions that also carry higher mortality rates in exposed populations (Naujokas et al., 2013; Parvez et al., 2008) . Several authors have suggested that the mechanism of action of As in the lungs is that it can enhance tissue inflammation (De et al., 2004; Nemery, 1990) , inducing respiratory function impairment by oxidative stress (Lantz and Hays, 2006) or by producing or increasing pulmonary fibrosis (Nemery, 1990; von Ehrenstein et al., 2005) .
Some studies have mentioned that a significant proportion of lung disease would originate in utero or during the early infancy (Merkus, 2003; Smith et al., 2006; Waalkes and Liu, 2008; Yuan et al., 2010) suggesting that the etiology of these disease are due in part to heritable changes to the genome (Smeester et al., 2011) , which can be induced by the exposure to toxicants during sensitive times of development. In infants born to arsenic exposed mothers an increased inflammatory responses have been reported (Fry et al., 2007) . Arsenic exposure alters markers of inflammation such as soluble receptor for advanced glycation endproducts (RAGE), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), which are related to remodeling of the extracellular matrix including lung tissue. Recently our research group reported that the arsenic exposure during in utero and early life was associated with impairment in the lung function and with abnormal sRAGE (soluble RAGE), MMP-9 and MMP-9/TIMP-1 levels (Olivas-Calderón et al., Toxicology and Applied Pharmacology 329 (2017) [140] [141] [142] [143] [144] [145] [146] [147] 2015). Lantz et al. (2007) found a significant negative correlation between RAGE sputum levels and total urinary inorganic arsenic.
Several novel mechanistic findings regarding arsenic's pathogenesis has been reported including As induced changes to the genome via epigenetic processes such as DNA methylation (Smeester et al., 2011) , histone maintenance, and mRNA expression (Niedzwiecki et al., 2013) . Alterations in DNA methylation associated with arsenic exposure have been evaluated in cells, animal models and in humans (Jensen et al., 2009; Reichard et al., 2007; Xie et al., 2007; Zhao et al., 1997; Zhong and Mass, 2001 ). Exposure to As has an impact on both hypomethylation and hypermethylation of repetitive genomic elements and in individual genes (Bailey and Fry, 2014) , with hypermethylation more prevalent in some studies (Jensen et al., 2009) . In the traditional model of the effects of DNA methylation, hypermethylation of cytosine-rich gene regions (CpG islands) in the promoters of target genes inhibits the initiation of transcription (Holliday and Pugh, 1975; Riggs, 1975) , which in turn, modifies protein expression and/or protein function. Chicoine et al. (2002) found an inverse correlation between levels of methylation of the MMP-9 promoter and the level of MMP-9 expression.
Based on our previous results Olivas-Calderón et al., 2015) and in the reported impacts of arsenic on DNA methylation in genes important for remodeling of the extracellular matrix, the present work was designed with the aim of determining the association between DNA methylation on promoters of extracellular matrix remodeling proteins (MMP9, TIMP1 and RAGE genes) with the sputum protein levels of these markers and with As urinary levels in our cohort of children exposed in utero and early life to arsenic through drinking water.
Materials and methods

Study population
The subjects included in this report are a subset of those reported in an earlier study . More than 500 children were evaluated; however, only 50 children were included in this study. We exclusively included only volunteers who were conceived in the studied rural communities, whose mothers remained throughout their entire pregnancies in these communities, those volunteers who remained as permanent residents of the same communities, who provided the biological samples and those with normal (less exposed group) and abnormal (more exposed groups) spirometric assessment. The participants were girls and boys aged 6-12 years residing in four rural communities where the highest arsenic tap water levels detected in the last 20 years ranged from 104 to 360 ppb. These communities received groundwater through the local water supply and the high As levels in the water were due, in part, to an over-extraction of water from the ground for crops. These communities form part of the geographic area knowns as Comarca Lagunera, which is located in the north-central part of Mexico and known to be an area where increased arsenic toxicity has been reported (Sampayo-Reyes et al., 2010; Recio-Vega et al., 2015) . The mean time of exposure of the studied population was 8.4 years (range 6-12 years).
Written informed consent was obtained from each participant and from their parents to obtain biological samples which were obtained at the time of interview. The study protocol was approved by the Ethics Committee of the School of Medicine at Torreon, University of Coahuila, Mexico.
Questionnaire application
Information was collected through in-person interviews and included socio-demographic variables (education, socioeconomic status, type of kitchen, type of fuel used for cooking), lifetime residential history, lifestyle factors (secondhand smoke defined as someone smoking regularly in the same room at home, and exercise), parent's occupational history, water source types (municipal tap water, bottled, other), current medications, medical history, and diet. Water consumption habits were ascertained through a standardized questionnaire. Asthmatic volunteers confirmed by a doctor were not included in the study.
As measurement in drinking water, urine and toenails
Drinking water samples (well) were collected from each rural community included in the study and analyzed for inorganic arsenic levels. No other contaminants in the drinking water were assessed. Well water samples from each rural community are representative of the water that participants drank and it is provided through the unique local water supply system. Individual exposure was assessed based on the total arsenic urinary level. A first morning void urine sample was collected in two sterile 120-mL screw-topped polypropylene containers. The urine samples were obtained during the late autumn and winter seasons to avoid the hottest seasons when there is much higher water consumption and children have increased outdoor activities. Also we cut children's nails with a new sterilized nail clipper for each child. Parents were instructed to wait two weeks before study and then we clipped nails from all ten of their children's toes and placed the clippings in small brown manila envelopes. The in utero and childhood As exposure was calculated as the As tap water level mean registered in the studied communities during the period of 2000-2013 (mean 152.1 ± 49.3 μg/L; range 104-275 μg/L). Arsenic content were analyzed at Arizona Laboratory for Emerging Contaminants University of Arizona, Tucson, Arizona. Total As concentration in urine and toenails were measured by inductively coupled plasma mass spectrometry (ICP-MS) (7700× ICP-MS, Agilent Technologies, Santa Clara, CA, USA). Briefly, arsenic species in urine [As V , As III , monomethylarsonic acid (MMA V ), dimethylarsinic acid, (DMA V ) and arsenobetaine] was performed using high performance liquid chromatography (Agilent 1100) with inductively coupled plasma mass spectroscopy (Agilent 7500) (HPLC/ICP-MS) (Agilent 1100 HPLC with Hamilton PRP-X100 column) with a method adapted from Milstein et al. (2003) . Additional exposure to DMA or to organic arsenic metabolized in the body to DMA, which usually is attributable to consumption of seafood such as bivalves and seaweeds, was considered minimal because such sea-foods are essentially never eaten in this area. Arsenic metabolism efficiency was calculated using the following formulas proposed by Del Razo et al. (1997) , first methylation = MMA V /(As V + As III ); second methylation = DMA V /MMA V . According with their total arsenic urinary level, subjects were divided in three study groups (tertiles) with the aim to search the effects related to exposure level (Group 1: b 59 μg/L; Group 2: ≥ 59 b 256 μg/L; Group 3: ≥256 b 664 μg/L).
Sputum analysis
Sputum induction was performed as previously described (Burgess et al., 2013) . Sputum induction was performed by using a sterile 5% saline aerosol (Baxter, Deerfield, IL, USA) generated by using Comp Air XLT, Compressor Nebulizer Systems (Model NE-C25, Omcron Healthcare, Bannockburn, Illinois, USA) set on maximum output. Subjects were encouraged to cough up every 2 min for a period of 30 min and the sputum was collected. Prior to each cough, subjects were asked to discard any saliva to minimize salivary contamination of the sputum sample. Sputum samples were treated with 10% sputolysin (Calbiochem, San Diego, CA, USA) containing penicillin streptomycin to inhibit bacterial growth. Samples were processed in the Environmental Health Laboratory. The sputum samples were centrifuged to separate cells from the supernatant, which was stored at −70°C. Sputum supernatant samples were analyzed in duplicate for levels of sRAGE, MMP-9 and TIMP1 using a commercially available enzyme-linked immunoabsorbent assay (ELISA) (Biovendor LLC, Asheville, NC 28806, USA). A uniform initial sample dilution was performed on all samples to maximize the number of samples with concentrations within the standard range for the sRAGE, MMP-9, TIMP-1.
DNA methylation analysis by MassARRAY
Peripheral blood samples were collected into EDTA vacutainer tubes, and extraction of genomic DNA material was carried out with DNAzol according to the manufacturer's instructions (DNAzol R BD, Cincinnati, OH, USA). Sodium bisulfite-treated genomic DNA was prepared according to the manufacturer's instructions of EZ DNA Methylation-Gold ™ Kit (Zymo Research) at the Department of Cellular and Molecular Medicine and Cancer Center from University of Arizona. Sodium bisulfitetreated DNA (5 ng) was seeded into a region-specific PCR incorporating a T7 RNA polymerase sequence as described by the manufacturer (Sequenom). Resultant PCR product was then subjected to in vitro transcription and RNase A cleavage using the MassCLEAVE T-only kit, spotted onto a Spectro CHIP array, and analyzed using the MassARRAY Compact System matrix-assisted laser desorption/ionization-time-offlight mass spectrometer (Sequenom). Each sodium bisulfite-treated DNA sample was processed in two independent experiments. Data were analyzed using EpiTyper software (Sequenom) as described previously (Novak et al., 2008; Coolen et al., 2007) . Primer sequences were designed using EpiDesigner. Primer sequences are available upon request.
The methyl DNA immunoprecipitation microarrays and data analysis
The methylated fraction of DNA was obtained by immunoprecipitation as described (Novak et al., 2006) at the University of Arizona's Genetics Core. Input and immune-precipitated DNAs were amplified, labeled and analyzed on Human Promoter arrays as described (Jensen et al., 2009) . The magnitude of the microarray methylation was directly correlated with the degree of methylation as determined by MassARRAY.
We analyzed the percentage of DNA methylation in promoter regions of MMP9, TIMP1 and RAGE genes. The DNA methylation levels of fragments were calculated using the weighted formula previously described (Coolen et al., 2007) : Average methylation = [(1/n)SNR1 + (2/n)SNR2 + …, + (n/n)SNRn] / [SNRNOME + SNR1 + SNR2…, + SNRn] where SNR is the signal-to-noise ratio of either the unmethylated peak (NOME) or one of the methylated peaks (1, 2, …, n) associated with a fragment containing n CG sites.
Subjects were divided in three study groups (tertiles) according with their DNA methylation levels with the aim to search the effects related to DNA methylation level ( 
Statistics
Independent and dependent variables were described according to their frequency and distribution measurements (arithmetic mean and standard deviation). The F test was used when the variable was divided into more than two categories, and the Mann Whitney test was used to compare different frequencies of DNA methylation and levels of arsenic when dichotomous variable categories were analyzed. This method permitted us to establish statistical differences among groups for each dependent variable. Linear regression models were used to assess crude or independent associations between the different DNA methylation levels with arsenic urine and toenail concentrations. In all multivariable models, we included those statistical significant variables (P b 0.05) identified in the bivariate model and those possessing biological plausibility (age, gender, second hand smoking). All analyses were performed using the statistical software STATA 11.0 (Stata Corp., College Station, TX, USA).
Results
Socio-demographic, anthropometric characteristics and life style
Most of the socio-demographic, anthropometric characteristics and life style variables of the volunteers were similar between groups of study, except gender, there were more girls in the most exposed groups (2 and 3) than in the less exposed group (1) (P b 0.05). On the other hand, the frequency of use of tap water for cooking was slightly higher in participants from Group 3, however, it was not significantly different from the other groups (P = 0.30). No differences were found in drinking of tap water at home or at school between the studied groups (P N 0.05) ( Table 1) . Table 2 Arsenic urinary and toenail levels in the studied population. Results are shown as arithmetic mean and standard deviation.
Group 1 (n = 16) Group 2 (n = 17) Group 3 (n = 17) 
Urinary and toenail arsenic concentrations
Mean total arsenic concentration in the entire population in urine and toenails was 191.5 ± 165.5 (μg/L) and 2.84 ± 1.61 (μg/g), respectively. The correlation found between As tap water level with As urinary level was 0.69 and with As toenails levels was 0.55. Total As, As III , MMA, DMA and inorganic As (iAs) levels were significantly higher (P b 0.05) in subjects from Groups 2 and 3 than in Group 1; meanwhile, As V was lower in Groups 2 and 3 ( Table 2 ). The percentages of MMA and DMA were similar between groups (P N 0.05) ( Table 2 ). The first methylation rate was significantly higher in Group 3; as well as, the second methylation in Group 2 (P b 0.05). Total As in toenails was higher in Group 2 and 3 compared with that found in subjects from Group 1 ( Table 2) .
3.3. DNA methylation in promoter regions of MMP9, TIMP1 and RAGE genes and arsenic exposure DNA methylation level in promoter region of MMP9 was significantly higher (P = 0.03) in the subjects most exposed (Group 3) than in the less exposed (Group 1) (Table 3) . A slight increased DNA methylation in the promoter region of TIMP1 was recorded in participants from Groups 3 but this increase was not statistically significant (P N 0.05) (Table 3) . Likewise, DNA methylation in the promoter region of RAGE was higher in Groups 2 and 3 than in Group 1, but this difference was again not statistically significant (P N 0.05) ( Table 3) .
MMP9, TIMP1 and RAGE sputum levels and DNA methylation
A reduction of 47% of MMP9 sputum levels were observed in those subjects with the higher level of DNA methylation when compared with that seen in those with the lower methylation level; however, that difference was not statistically significant (P N 0.05). TIMP1 sputum levels were similar between methylation groups. RAGE sputum levels were significantly higher (62%) (P b 0.05) in subjects with the mid methylation level when compared with the observed in subjects from the low methylation level group (Table 4) .
Associations between DNA methylation and arsenic exposure
In the crude linear regression model, no associations were found between the As species measured with the level of DNA methylation in the promoter regions of MMP9 and TIMP1, but a positive association was registered between MMP9 methylation with toenail As levels ( Table 5) . With regard to the DNA methylation in the promoter of RAGE, three positive associations were observed with iAs, MMA V , and %MMA (P b 0.05); meanwhile, a negative association (P b 0.05) was found with the second methylation (Fig. 1) . In the adjusted linear regression model, all associations recorded in the crude model remained statistically significant (Table 5 ).
Association between DNA methylation with MMP9, TIMP1 and RAGE sputum levels
In the bivariate or multivariate linear regression models, no significant associations between the DNA methylation levels of promoter regions assessed with the sputum protein concentrations were registered (Table 6 ). Fig. 2 shows the relationship between DNA methylation levels of the promoter region of MMP9 with MMP9 sputum levels.
Discussion
To our knowledge, this is the first study evaluating the association between the DNA methylation of three genes implicated in remodeling of extracellular matrix (MMP9, TIMP1 and RAGE) with the sputum inflammatory marker levels and with As urinary concentration in a cohort of children exposed in utero and early life to this metalloid.
The studied subjects have been chronically exposed to high As levels through drinking water (mean 152.1 ± 49.3 μg/L; range 104-275 μg/L) and N75% of them had As urinary levels N50 μg/L (mean 191.5 μg/dL). These high levels are impacting the children's health as reveled in our previous studies in which we found that chronic arsenic exposure modified negatively the sRAGE, MMP-9 and MMP-9/TIMP-1 sputum levels and increased significantly the frequency of abnormal spirometric patterns (Olivas-Calderón et al., 2015; Recio-Vega et al., 2015) . However, in spite of high and chronic exposure levels, skin lesions were not observed in the assessed children.
Arsenic mediates its toxicity by generating oxidative stress, causing immune dysfunction, promoting genotoxicity, hampering DNA repair, disrupting signal transduction (Hunt et al., 2014) and inducing changes to the genome via epigenetic processes such as DNA methylation (Argos, 2015; Boellmann et al., 2010; Green et al., 2016; Rager et al., Gene Group 1 (n = 16) Group 2 (n = 17) Group 3 (n = 17) MMP9 0.13 ± 0.07 0.16 ± 0.07 0.17 ± 0.03 ⁎ TIMP1 0.13 ± 0.10 0.12 ± 0.11 0.14 ± 0.10 RAGE 0.68 ± 0.16 0.73 ± 0.12 0.73 ± 0.10 ⁎ P b 0.05: Mann-Whitney test (Groups 2 or 3 vs Group 1). 2015; Ren et al., 2011) . The mechanism by which As influences DNA methylation after exposure to the metalloid is not clear; however, it is widely known that arsenic methyltransferase uses the same methyl donor (SAM) as DNA methyltransferase and other methyltransferases. Changes in SAM availability due to As exposure/biotransformation may therefore disturb DNA methylation patterns and subsequently influence disease risk by altering the expression of key genes (Bailey et al., 2013) . In the traditional model of the effects of DNA methylation, genes with high levels of DNA methylation had, on average, lower expression levels, whereas genes with low expression displayed higher levels of DNA methylation. This finding is consistent with previous observations comparing the methylation levels of genes according to their expression category (Rojas et al., 2015) . Several studies have evaluated DNA methylation in vitro, in vivo and in human populations exposed to different doses of arsenic (Chanda et al., 2006) . All these studies have reported contradictory results in terms of DNA methylation levels, some of them demonstrated that arsenic exposure is associated with hypomethylation (Intarasunanont et al., 2012; Tajuddin et al., 2013; Wilhelm et al., 2010) and others with hypermethylation (Hossain et al., 2012; Kile et al., 2012; Lambrou et al., 2012; Majumdar et al., 2010; Pilsner et al., 2012) at various genetic loci. It have been suggested that the dose and the time at which subjects are exposed to As play an important role in the DNA methylation level. Majumdar et al. (2010) showed that exposures to 250-500 μg/L of arsenic in drinking water results in global hypermethylation, but concentrations above 500 μg/L of arsenic results in global hypomethylation. Another major area of interest has been the relationship between iAs biotransformation and the DNA methylome (Bailey and Fry, 2014) . The efficiency of iAs biotransformation is believed to be an important factor in the development of iAs-associated diseases, because several iAs metabolites are biologically reactive and toxic (Bailey and Fry, 2014; Tseng, 2007) . In our study, we quantified As metabolites and calculated percentages of As and Fig. 1 . Linear regressions between DNA methylation in promoter regions and arsenic levels where: A. RAGE methylation levels and iAs urinary levels. B. RAGE methylation levels and MMA V urinary levels. C. RAGE methylation levels and % MMA urinary levels. D. RAGE methylation levels and second methylation of As. E. MMP9 methylation levels and total As toenail levels. efficiency of methylation and their association with DNA methylation of promoter regions. The studied population has been exposed to high arsenic levels for N6 years and our data suggest that effectively time of exposure, dose of exposure and As methylation profile play an important and different role in DNA methylation at least in the promoter of the evaluated genes. Indeed, the DNA methylation in the promoter of RAGE was positively associated with two acute As biomarkers (iAs and %MMA urinary levels); whereas, the DNA methylation in the promoter of MMP9 was positively associated with the long term As biomarker (As toenail levels) and the DNA methylation in the promoter of RAGE and TIMP1 was positively associated with the second and first methylation of As, respectively. Then, the evaluated genes exhibited different susceptibility to DNA methylation because these genes responded different to As exposure (time, dose and methylation profile) and these differences in terms of methylation could explain some contrasting results obtained by different authors. Therefore, and because the different susceptibility in DNA methylation found in our study, diverse As scenarios and other variables such as age, race, genetics, environment, style life, health status, kind of cells evaluated, and genes evaluated must be considered and evaluated when DNA methylation level will be assessed. Literature has described other important variables that may influence the degree of DNA methylation and among of them are age (Bollati et al., 2009; Terry et al., 2011 ), gender (El-Maarri et al., 2011 Wilhelm et al., 2010; Zhang et al., 2011; Zhu et al., 2010) and intake of acid folic (Jung et al., 2011; Niedzwiecki et al., 2013) . In our studied children, we did not find that these variables modified statistically DNA methylation, which suggest that other gender-specific factors such as hormone levels, socio-economic factors and lifestyles may subsequently influence other stages of life, resulting in differences in DNA methylation. When we compare the degree methylation of DNA between children from mothers who took folic acid during pregnancy (85%) with those who did not, we did not find statistical differences in DNA methylation levels. Our results support that folate might influence DNA methylation only under conditions in which folate is limiting as was commented previously by Niedzwiecki et al. (2013) .
It has been reported that disturbs in DNA methylation levels influence disease risk by altering the expression of key genes (Bailey et al., 2013) . Genes with high levels of DNA methylation had, on average, lower expression levels, whereas genes with low expression displayed higher levels of DNA methylation. Limited works assessing DNA methylation of extracellular matrix remodeling genes and gene expression have been reported. Chicoine et al. (2002) evaluated the correlation between the level of methylation of the MMP-9 promoter and the level of MMP-9 expression and they found an inverse relationship between these variables which indicates that methylation may contribute to the suppression on transcriptional activity of MMP-9 promoter. We evaluated DNA methylation in promoter regions of MMP9, TIMP1 and RAGE because these are rich regions in CpG islands and can be the most predictive of gene expression levels. Although we did not evaluate gene expression, we quantified their respective proteins sputum levels as a marker of gene transcriptional activity. When the specific sputum protein levels were evaluated according with DNA methylation grade (low, mid and high), we found that at the mid RAGE methylation level, a significant increase in its sputum protein concentration was registered. On the other hand, at the high MMP9 and TIMP1 methylation levels a tendency to the decrement in the MMP9 and TIMP1 protein levels was registered (P N 0.05). These last results are in agreement with previous studies in which a negative relationship between promoter CpG island/CpG island shore methylation and gene expression was observed (Bell et al., 2011; van Eijk et al., 2012) . No significant associations between DNA methylation with sputum protein concentrations were found. The alterations in DNA methylation level and its effects on its sputum protein concentrations found in our study, showed a negative effect on the synthesis of their respective proteins, which in turn, modifies the biological process in which they are involved causing or predisposing to disease.
It is important to point out that the degree of methylation of specific genes may vary according to the type of cell used to assess it. DNA methylation patterns are tissue specific, and one critical limitation for human epigenetic studies is that tissues that are relevant for disease etiology cannot be easily obtained in most cases from patients and study participants Terry et al., 2011) . In our study, we used peripheral blood white cells, which are not known to be direct target of As-induced carcinogenesis (Niedzwiecki et al., 2013) or diseases. However, As trioxide is a highly effective therapeutic drug for the treatment of acute promyelocytic leukemia (Powell et al., 2010) ; therefore, we can assume that As distributes to bone marrow progenitor cells and influences their cellular function including white cells (Petrie et al., 2009 ); nevertheless, it does not know the extent to which methylation of peripheral blood white cell DNA reflects the methylation of other target tissues (Niedzwiecki et al., 2013) . Therefore, the previous factors must be considered and analyzed integrally when results from different studies are discrepant.
Further studies evaluating the methylation and expression of other extracellular matrix remodeling genes and its specific protein levels in a bigger sample are required with the aim to increase the knowledge about the abnormal lung function in subjects chronically exposed to arsenic.
Conclusion
Arsenic levels were positive associated with the DNA methylation of extracellular matrix remodeling genes which contributes to an increase in RAGE sputum levels and a tendency to the decrement in the MMP9 and TIMP1 protein levels, which in turn could modifies the biological process in which they are involved causing or predisposing to lung diseases.
